Select for export Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directions Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1556/2054.2022.00211 Copy citation Copy BibTeX Journal of Psychedelic Studies 2022-06-08 Annie M. McCartney, H. T. McGovern, Alexander De Foe OpenAlex Published psilocybin DepressionAnxietyReceptor Pharmacology Clinical Trial More
Select for export Neuropharmacological analysis of the anti-addictive and therapeutic effects of psilocybin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.21083/surg.v14i1.6870 Copy citation Copy BibTeX SURG Journal 2022-05-31 Anthony Principe OpenAlex Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export The safety and efficacy of psilocybin therapy in patients with cancer and major depressive disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1200/jco.2022.40.16_suppl.12097 Copy citation Copy BibTeX Journal of Clinical Oncology 2022-05-31 Manish Agrawal, Paul Thambi, Sarah Shnayder OpenAlex Published psilocybin DepressionAnxietyClinical Trial Clinical Trial More
Select for export Review of potential psychedelic treatments for PTSD. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jns.2022.120302 PubMed 35700643 Copy citation Copy BibTeX Unknown journal 2022-05-29 Henner RL, Keshavan MS, Hill KP. Europe PMC Published psilocybin PTSDMechanism of ActionClinical Trial Clinical Trial More
Select for export Unraveling the Mysteries of Mental Illness With Psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7759/cureus.25414 PubMed 35769681 Copy citation Copy BibTeX Unknown journal 2022-05-26 Sotille R, Singh H, Weisman A, Vida T. Europe PMC Published psilocybinpsilocin DepressionNeuroplasticityReceptor Pharmacology Clinical Trial More
Select for export Psilocybin Versus Ketamine - Fast Acting Antidepressant Strategies in Treatment-resistant Depression Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2022-05-19 National Institute of Mental Health, Czech Republic ClinicalTrials.gov CLINICAL TRIAL psilocybinpsilocin DepressionNeuroplasticityBrain Imaging Clinical Trial More
Select for export The Efficacy of Psilocybin in the Treatment of Depression andAnxiety: A Meta-Analysis Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2174/2666082218666220513142002 Copy citation Copy BibTeX Current Psychiatry Research and Reviews 2022-05-15 Andrew Hodge, Suporn Sukpraprut-Braaten, Robert Strayhan OpenAlex Published psilocybin DepressionAnxietyReceptor Pharmacology Randomized Controlled Trial More
Select for export Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy in Major Depression Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2022-04-28 University of Zurich ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyNeuroplasticity Clinical Trial More
Select for export P388. Open Label Psilocybin Administration in Severely Treatment Resistant Depression No abstract availability was recorded for this entry. Details DOI 10.1016/j.biopsych.2022.02.624 Copy citation Copy BibTeX Biological Psychiatry 2022-04-27 Scott Aaronson, Tammy Miller, Samuel Rudow, MacKenzie Forbes, Trisha Suppes OpenAlex Published psilocybin DepressionAnxietyClinical Trial Randomized Controlled Trial More
Select for export Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/14740338.2022.2066650 PubMed 35426754 Copy citation Copy BibTeX Expert Opinion on Drug Safety 2022-04-26 Rossi GN, Hallak JEC, Bouso Saiz JC, Dos Santos RG. Europe PMC Published psilocybin DepressionMechanism of ActionClinical Trial Randomized Controlled Trial More
Select for export Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.pharmthera.2022.108195 PubMed 35489438 Copy citation Copy BibTeX Unknown journal 2022-04-26 Raut SB, Marathe PA, van Eijk L, Eri R, Ravindran M, Benedek DM Europe PMC Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export Increased global integration in the brain after psilocybin therapy for depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41591-022-01744-z PubMed 35411074 Copy citation Copy BibTeX Nature Medicine 2022-04-10 Daws RE, Timmermann C, Giribaldi B, Sexton JD, Wall MB, Erritzoe D Europe PMC Published psilocybin DepressionBrain ImagingReceptor Pharmacology Randomized Controlled Trial More
Select for export Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-022-08085-4 PubMed 35393455 Copy citation Copy BibTeX Scientific Reports 2022-04-06 Jones G, Ricard JA, Lipson J, Nock MK. Europe PMC Published psilocybin AddictionClinical TrialObservational Study Clinical Trial More
Select for export Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel-Mediated Cardiotoxicity. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyab085 PubMed 34871422 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2022-03-31 Hackl B, Todt H, Kubista H, Hilber K, Koenig X. Europe PMC Published psilocybinpsilocin AgingClinical TrialSafety Clinical Trial More
Select for export Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fphar.2021.788155 PubMed 35431912 Copy citation Copy BibTeX Frontiers in Pharmacology 2022-03-30 Murphy R, Kettner H, Zeifman R, Giribaldi B, Kartner L, Martell J Europe PMC Published psilocybin DepressionEmotional ProcessingMystical Experience Randomized Controlled Trial More
Select for export Tentative identification of in vitro metabolites of O-acetylpsilocin (psilacetin, 4-AcO-DMT) by UHPLC-Q-Orbitrap MS. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/dta.3255 PubMed 35312166 Copy citation Copy BibTeX Drug Testing and Analysis 2022-03-28 Zhai W, Li L, Zhao J, Xiang P, Liu M, Shi Y Europe PMC Published psilocybinpsilocin PharmacologyBiomarkersEpigenetics Clinical Trial More
Select for export Psilocybin-Assisted Compassion Focused Therapy for Depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyg.2022.812930 PubMed 35401294 Copy citation Copy BibTeX Frontiers in Psychology 2022-03-24 Pots W, Chakhssi F. Europe PMC Published psilocybin DepressionClinical Trial Clinical Trial More
Select for export Demystifying Psychedelic Treatments in Psychiatry: Is Ego Dissolution the Solution? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2022.04.4.35 Copy citation Copy BibTeX Psychiatric News 2022-03-23 Michael Avissar, Adrian Jacques H. Ambrose OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export The promises and perils of psychedelic pharmacology for psychiatry. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41573-022-00421-7 PubMed 35301459 Copy citation Copy BibTeX Unknown journal 2022-03-16 McClure-Begley TD, Roth BL. Europe PMC Published psilocybin DepressionAnxietyPharmacology Clinical Trial More
Select for export Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.nsa.2022.100104 PubMed 40656230 Copy citation Copy BibTeX Neuroscience Applied 2022-03-06 Mertens LJ, Koslowski M, Betzler F, Evens R, Gilles M, Jungaberle A Europe PMC Published psilocybin DepressionClinical TrialSafety Clinical Trial More
